see the Legal Status page for official classification and FDA guidance
PlexusDx offers compounded semaglutide $189/mo month-to-month, or from $149/mo on the 6-month plan and compounded tirzepatide $289/mo month-to-month, or from $249/mo on the 6-month plan through licensed 503A pharmacies
Maintaining a high rating as review volume grows is significantly harder than earning high marks from a handful of early adopters, and this sustained performance suggests that Direct Meds delivers a reliably positive patient experience across a very large customer base
Note: Rounds to nearest $10 and integer trends
Ozempic was a medication that was approved by the FDA for the treatment of those with diabetes, and it was noted during studies and after approval that patients who were using Ozempic lost weight, which led to more studies on the use of Ozempic for weight loss and later an approval by the FDA in certain circumstances for those to use who are not diabetic
As your body loses weight on semaglutide, it naturally increases hunger signals and decreases energy expenditure to resist further loss
